Abstract
Idiopathic intracranial hypertension (IIH) is a condition characterized by increased intracranial pressure without a detectable cause. The most common symptom of IIH is a headache, which occurs in almost all cases at the time of diagnosis with various headache phenotypes. In clinical practice, diagnosis of headache attributed to IIH is given referring to the International Headache Society (IHS) criteria of the International Classification of Headache Disorders. In the present publication, we consider how the IHS diagnostic criteria for headache attributed to intracranial idiopathic hypertension have evolved through the years.
Similar content being viewed by others
References
Jensen RH, Radojicic A, Yri H (2016) The diagnosis and management of idiopathic intracranial hypertension and the associated headache. Ther Adv Neurol Disord 9(4):317–326
Craig JJ, Mulholland DA, Gibson JM (2001) Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995). Ulster Med J 70(1):31–35
Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S (2004) Idiopathic intracranial hypertension (pseudotumour cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur J Ophthalmol 14(1):48–54
Mollan SP, Markey KA, Benzimra JD, Jacks A, Matthews TD, Burdon MA, Sinclair AJ (2014) A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol 14(6):380–390
Yri HM, Jensen RH (2015) Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study. Cephalalgia 35(7):553–562
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71(6):693–701
Yri HM, Wegener M, Sander B, Jensen R (2012) Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259(5):886–894
Curone M, Peccarisi C, Bussone G (2015) Headache attributed to intracranial pressure alterations: applicability of the International Classification of Headache Disorders ICHD-3 beta version versus ICHD-2. Neurol Sci 36(Suppl 1):137–139
Friedman DI, Quiros PA, Subramanian PS, Mejico LJ, Gao S, McDermott M, Wall M, the NORDIC IIHTT Study Group (2017) Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache 57(8):1195–1205
Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1–96
Headache Classification Subcommittee of the International Society (2004) The international classification of headache disorders: 2nd edition. Edition. Cephalalgia 24(Suppl 1):1–160
Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1–211
Olesen J (2005) The international classification of headache disorders. 2nd edition (ICHD-II). Rev Neurol (Paris) 161(6–7):689–691 Review
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
This article does not contain any study with human subjects performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Curone, M., Tullo, V. & Bussone, G. Headache attributed to IIH: clinical evolution in IHS criteria through the years. Neurol Sci 40 (Suppl 1), 55–58 (2019). https://doi.org/10.1007/s10072-019-03795-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-03795-6